SCHEMBL29545540

SCHEMBL29545540

COc1ccc2nccc(-c3nn4c(c3Cl)C(=O)NC[C@H]4C)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4C Q9H3R0 2/20 0.38
LMNA P02545 1/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
CDK5 Q00535 3/20 0.37
CDK5R1 Q15078 3/20 0.37
MAPKAPK2 P49137 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
GABRA1 P14867 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 1/20 0.35
CCR8 P51685 2/20 0.35
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29544629 1.00 NCF1 (0.39) NCF1KDM4EMAPK1NPSR1KDM4C
SCHEMBL29544635 0.87 NCF1 (0.38) NCF1ACVR1
SCHEMBL29544676 0.87 NCF1 (0.38) NCF1ACVR1
SCHEMBL29544338 0.86 GRM2 (0.36)
SCHEMBL29544372 0.86 GRM2 (0.36)
SCHEMBL29544648 0.82 RIPK2 (0.35) NCF1KDM4EMAPK1NPSR1KDM4C
SCHEMBL29544685 0.82 RIPK2 (0.35) NCF1KDM4EMAPK1NPSR1KDM4C
SCHEMBL29545124 0.76 USP7 (0.35) ACVR1
SCHEMBL29544665 0.76 USP7 (0.35) ACVR1
SCHEMBL29544573 0.75 PIK3C3 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed